The Chinese tech giant is establishing a lead in a fiercely competitive sector, and its billionaire founder is back in favour ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each year as ...